by Brad N. Taylor, Ph.D. | Feb 16, 2023
The emergence of organ-specific 3D tissue culture technology is a scientific breakthrough that promises a new era of disease research and discovery. Organoids are complex, 3-dimensional collections of cells grown in culture to mimic the organization of human organs....
by Brad N. Taylor, Ph.D. | Dec 20, 2022
In celebration of the holidays, we take a look back at some of the most exciting events and achievements of the year…and a look forward to what the New Year will bring. Science enthusiasts everywhere, your attention please! Today we thank the hardworking team at...
by Brad N. Taylor, Ph.D. | Dec 12, 2022
CAR T therapy is a revolutionary new cancer treatment that relies on engineering a patient’s immune cells. High transduction efficiency is key to its therapeutic success. Nucleus Biologics has launched NB-ROC™, a serum free media formulated by T cell researchers with...
by Brad N. Taylor, Ph.D. | Oct 11, 2022
Nucleus Biologics is proud to announce that it has obtained ISO 13485:2016 certification for the manufacture and distribution of media for the cell and gene therapy industry. The company is one of the few small lot custom media suppliers for the cell and gene therapy...
by Brad N. Taylor, Ph.D. | Aug 31, 2022
Cell and gene therapy products are only as good as their cellular building blocks— therefore cell culture media should first and foremost be designed to support consistent and optimal cellular performance. Welcome to Part 2 and the final part of our blog series...
by Brad N. Taylor, Ph.D. | Aug 9, 2022
The key to every successful therapy is consistency. Cell therapy manufacturers need solutions that allow them to efficiently harness the ability of a living cell to respond to its environment, while simultaneously delivering replicable and consistent quality...
